Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

The Safety and Efficacy of CD33 CAR-T Therapy for RR AML after HSCT

Yuehui Lin, Defeng Zhao, Biping Deng, Dan Liu, Hong Yan, Biyi Li, Yu Xia, Ruyue Zheng, Tong Wu, Chunrong Tong

Blood (2024) 144 (Supplement 1): 3467.

https://doi.org/10.1182/blood-2024-207659

Published: 2024

Journal Articles

The Primary Results of R-MTO Regimen (Rituximab, Methotrexate, Thiotepa, and Orelabrutinib) As the First-Line Induction Therapy Followed By Autologous Stem Cell Transplantation in Newly Diagnosed Primary Central Nervous System Lymphoma

Haichen Wei, Lijie Xing, Dan Liu, Hui Wang, Ping Li, Zengjun Li

Blood (2024) 144 (Supplement 1): 1742.

https://doi.org/10.1182/blood-2024-204844

Published: 2024

Journal Articles

Transcriptome Data Analysis of 80 B ALL Patients in China

Yuehui Lin, Dan Liu, Yu Xia, Yu Xia, Tong Wu, Qinlong Zheng

Blood (2024) 144 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2024-209904

Published: 2024

Journal Articles

A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP +/- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma

Hui Wang, Lijie Xing, Dan Liu, Haichen Wei, Ke Lu, Qiang He, Linna Xie, Ji Ma, Lugui Qiu, Zengjun Li

Blood (2024) 144 (Supplement 1): 6307.

https://doi.org/10.1182/blood-2024-206243

Published: 2024

Journal Articles

The Safety and Efficacy of Inotuzumab Treatment for Elderly Unfit r/r B ALL

Yuehui Lin, Dan Liu, Yu Xia, Tong Wu, Chunrong Tong

Blood (2024) 144 (Supplement 1): 5891.

https://doi.org/10.1182/blood-2024-210481

Published: 2024

Journal Articles

Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial

Lindsey E. Roeker, Jennifer A. Woyach, Chan Y. Cheah, Catherine C. Coombs, Nirav N. Shah, William G. Wierda, Manish R. Patel, Nicole Lamanna, Donald E. Tsai, Binoj Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C. McNeely, Jennifer R. Brown

Blood (2024) 144 (13): 1374–1386.

https://doi.org/10.1182/blood.2024024510

Published: 2024

Includes: Supplemental data

Journal Articles

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

Lijie Xing, Haichen Wei, Dan Liu, Hui Wang, Ping Li, Linna Xie, Zengjun Li

Blood (2023) 142 (Supplement 1): 6228.

https://doi.org/10.1182/blood-2023-186219

Published: 2023

Journal Articles

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Yuehui Lin, Tong Wu, Dan Liu, Chunrong Tong

Blood (2023) 142 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2023-186153

Published: 2023

Journal Articles

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

Blood (2022) 140 (Supplement 1): 11962–11963.

https://doi.org/10.1182/blood-2022-162507

Published: 2022

Journal Articles

Why Don't Asians Get Chronic Lymphocytic Leukaemia? It's in Their Genes

Shenmiao Yang, Dan Liu, Wenbing Liu, Xiaojun Huang, Qian-fei Wang, Robert Peter Gale

Blood (2022) 140 (Supplement 1): 12365–12366.

https://doi.org/10.1182/blood-2022-165042

Published: 2022

Journal Articles

Identification of Chemo-Resistant Residual Cell Population in Pediatric AML of Complete Remission By Single Cell RNA Sequencing

Shuting Jiang, Fuhong He, PhD, Li Gao, MD, Aili Chen, PhD, Yixin Hu, MD, Liyan Fan, MD, Lin Zhang, MS, Yongping Zhang, Haiyang Hu, Dan Liu, MS, Zihan Zhou, Yanxun Su, Lei Qin, Jun Lu, MD, Peifang Xiao, MD, Raul Ribeiro, MD, Shaoyan Hu, MD PhD, Qian-fei Wang, PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-141139

Published: 2020

Journal Articles

A Novel t(9;22;11) Translocation Variant Involving 11q23 in a Patient with Chronic Myeloid Leukemia

Lin Yuehui, MD, Qinglong Zheng, Tong Wu, MD, DAN LIU

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-138460

Published: 2020

Journal Articles

Stemness Signature Defined By Logistic Regression Machine Learning and Artificial Intelligence Predicts Outcomes in Diffuse Large B-Cell Lymphoma

Xiao-jie Liang, Na Yao, Dan Liu, Hai-ying Chen, Xin Xu, Jing-Wen Wang, Ken H. Young, Liang Wang

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-141791

Published: 2020

Journal Articles

Differential Expression of CD49f Discriminates the Independently Emerged Hematopoietic Stem Cells and Erythroid-Biased Progenitors

Ai-Ning Xu, Dan Liu, Yu-Ting Dai, Fan Zhang, Jian Shen, MSc, Cheng-Long Hu, Chun-Hui Xu, Yuan-Liang Zhang, Yin-Yin Xie, Qiu-Hua Huang, Peng-Fei Xu, Lan Wang, Lin Cheng, Jinyan Huang, PhD, Zhu Chen, PhD, Sai-Juan Chen, PhD, Xiao-Jian Sun, PhD

Blood (2019) 134 (Supplement_1): 3700.

https://doi.org/10.1182/blood-2019-130429

Published: 2019

Journal Articles

Myeloid-Derived Suppressor Cells (HLA-DR -/low CD16 - CD33 + ) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

Ke Wang, Meng Lv, Ying-Jun Chang, Xiang-Yu Zhao, Xiao-Su Zhao, Yuan-Yuan Zhang, Yu-Qian Sun, MD, Zhi-Dong Wang, Pan Suo, Yang Zhou, Dan Liu, Shu-Zhen Zhai, Yan Hong, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 72.

https://doi.org/10.1182/blood-2018-99-114291

Published: 2018

Journal Articles

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

Dan Liu, Peiling Zhang, MD, Fuhong He, PhD, Yueying Li, MD, Wenbing Liu, Xin Liu, PhD, Qianfei Wang, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2018-99-117495

Published: 2018

Journal Articles

Clinical Subtypes, Molecular Features and Treatment Strategies of Aggressive NK-Cell Leukemia: A Multicenter Analysis of 113 Patients

Liang Huang, MDPhD, Yuting Tang, MD, Di Wang, MD PhD, Hui Luo, MD, Min Xiao, MD PhD, Dan Liu, Na Wang, MD PhD, Jianfeng Zhou, MD PhD, Qianfei Wang, PhD

Blood (2017) 130 (Supplement 1): 2796.

https://doi.org/10.1182/blood.V130.Suppl_1.2796.2796

Published: 2017

Journal Articles

Downregulation of SATB1 Increase the Invasiveness of Jurkat Cell Via Activation of the WNT/Beta-Catenin Signaling Pathway in Vitro

Xiaodan Luo, Lihua Xu, Dan Liu, Yaya Wang, Xiaohong Wu, Huo Tan

Blood (2015) 126 (23): 4825.

https://doi.org/10.1182/blood.V126.23.4825.4825

Published: 2015

Journal Articles

ATF4 plays a pivotal role in the development of functional hematopoietic stem cells in mouse fetal liver

Blood (2015) 126 (21): 2383–2391.

https://doi.org/10.1182/blood-2015-03-633354

Published: 2015

Includes: Supplemental data

Journal Articles

PU.1 Is Essential For MLL Leukemia Via Activation Of The Meis/HOX Pathway and A Monocytic Cytokine Mediated Anti-Apoptotic Inflammatory Program

Blood (2013) 122 (21): 1276.

https://doi.org/10.1182/blood.V122.21.1276.1276

Published: 2013

NARROW

The Safety and Efficacy of CD33 CAR-T Therapy for RR AML after HSCT

The Primary Results of R-MTO Regimen (Rituximab, Methotrexate, Thiotepa, and Orelabrutinib) As the First-Line Induction Therapy Followed By Autologous Stem Cell Transplantation in Newly Diagnosed Primary Central Nervous System Lymphoma

Transcriptome Data Analysis of 80 B ALL Patients in China

A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP +/- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma

The Safety and Efficacy of Inotuzumab Treatment for Elderly Unfit r/r B ALL

Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

Why Don't Asians Get Chronic Lymphocytic Leukaemia? It's in Their Genes

Identification of Chemo-Resistant Residual Cell Population in Pediatric AML of Complete Remission By Single Cell RNA Sequencing

A Novel t(9;22;11) Translocation Variant Involving 11q23 in a Patient with Chronic Myeloid Leukemia

Stemness Signature Defined By Logistic Regression Machine Learning and Artificial Intelligence Predicts Outcomes in Diffuse Large B-Cell Lymphoma

Differential Expression of CD49f Discriminates the Independently Emerged Hematopoietic Stem Cells and Erythroid-Biased Progenitors

Myeloid-Derived Suppressor Cells (HLA-DR -/low CD16 - CD33 + ) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

Clinical Subtypes, Molecular Features and Treatment Strategies of Aggressive NK-Cell Leukemia: A Multicenter Analysis of 113 Patients

Downregulation of SATB1 Increase the Invasiveness of Jurkat Cell Via Activation of the WNT/Beta-Catenin Signaling Pathway in Vitro

ATF4 plays a pivotal role in the development of functional hematopoietic stem cells in mouse fetal liver

PU.1 Is Essential For MLL Leukemia Via Activation Of The Meis/HOX Pathway and A Monocytic Cytokine Mediated Anti-Apoptotic Inflammatory Program

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only